Affinity Technologies receives Japanese patent for CyPath Lung test to detect lung cancer early: San Antonio Saturday, October 10, 2026, 13:00 Hrs [IST] bioAffinity Technologie ...
Lung cancer kills more people worldwide than any other malignancy, and the reason is painfully simple: it is usually caught ...
For patients with a stubborn lung infection, waiting more than a month to learn which bacterium is responsible can delay the next step in care. That is a particular problem with nontuberculous ...
A simple breath test could help doctors determine whether suspicious lung nodules are cancerous without immediately turning ...
SAN ANTONIO, September 30, 2026--bioAffinity and AvMEDICAL jointly presented CyPath Lung for the first time under their new distribution agreement at NAVREF 2026 Annual Conference.
GlobalData on MSN
FDA clears Cepheid’s multiplex respiratory panel test
The panel is designed to identify 13 common bacterial and viral respiratory pathogens from one nasopharyngeal swab.
As with palpation, make sure your hands are warm before you begin percussion. Start at the back and check each side to compare the quality of the sensation. It is key to keep the wrist loose and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results